A new study by Clalit Health Services, Sapir College and Ben Gurion University shows that the second booster reduces mortality  due to COVID-19 by 78% for  people 60 +

The rapid emergence of the omicron variant led to a global resurgence of COVID-19. Israeli authorities approved a 4th vaccine dose (second-booster) for individuals aged 60 and above who received a first booster dose four or more months earlier. This study included all 563,465 members of Clalit Health Services (the largest HMO in Israel) aged 60 to 100, eligible for the second-booster. Mortality due to COVID-19 among participants who received the second-booster was compared with participants who received one booster dose. Death due to Covid-19 was 78% lower in the second-booster group. Our findings support essential evidence on the life-saving value of second-boosters in elderly adults aged 60 and over.

ד"ר רונן ארבל

According to Dr. Ronen Arbel, Health Outcomes Researcher at Clalit Health Services and Sapir College: “The study of a large cohort of more than 500,000 participants aged 60 to 100 demonstrated that mortality rates due to COVID-19 were 78% lower after a second-booster dose. The main conclusion is that the second booster is lifesaving.”

This important research project, has received global attention, with articles published in Europe, Turkey, Canada, and the Philippines.

The Jerusalem Post

More News

קורס של אסתר חיות
Sapir Law School is proud to announce that the Honorable President (retired) Justice Esther Hayut will teach a unique workshop on "Law and the Holocaust" in the summer semester (2026) at Sapir Law School. Honorable President Hayut began her judicial career in 1990 as a Magistrate's Court judge in Tel Aviv. In 1997, she was appointed to the District Court, and in 2004, she was appointed to the Supreme Court. Judge Hayut served as chairwoman of the Central Elections Committee and chairwoman of the Judges' Ethics Committee.
Read more
ביקור הנהלת קרן גרמניה-ישראל GIF
Recently, we had the honor of hosting at the College the leadership of the German-Israeli Foundation for Scientific Research and Development (GIF), one of the most important and prominent foundations working to strengthen academic and scientific ties between Germany and Israel. The special visit of Verena Shifferman, CEO of the GIF, and Mirit Liran, Director of Research, was dedicated to the Western Negev region and to the College in particular, and concluded successfully. As part of the visit, a moving tour was held at the “Ketav VaShem” memorial site near Kibbutz Kfar Aza, guided by Dr.
Read more